Published in Metabolism on September 01, 1985
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet (1997) 3.19
Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology (1985) 2.32
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med (1998) 2.04
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab (1993) 1.94
Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord (2002) 1.77
Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord (2003) 1.74
Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest (2003) 1.71
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Investigation of exocrine pancreatic function by continuous infusion of caerulein and secretin in normal subjects and in chronic pancreatitis. Digestion (1976) 1.47
Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology (1981) 1.45
[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients]. J Radiol (2010) 1.43
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol (2000) 1.40
Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Clin Ther (1991) 1.40
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet. Am J Clin Nutr (1992) 1.37
Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism (1991) 1.36
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab (1989) 1.29
Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metabolism (1997) 1.27
WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med (2004) 1.24
Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut (1985) 1.19
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut (1985) 1.15
Atrioventricular block induced by swallowing in a patient with diffuse esophageal spasm. JAMA (1982) 1.14
Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab (1995) 1.14
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy (2007) 1.11
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10
Interdigestive gastroduodenal motility and serum motilin levels in patients with idiopathic delay in gastric emptying. Gastroenterology (1986) 1.09
Predictors of stable hypertension in young borderline subjects: a five-year follow-up study. J Cardiovasc Pharmacol (1986) 1.09
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) (2007) 1.09
Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat Rep (1982) 1.08
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. Ann Nutr Metab (1989) 1.06
Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol (2000) 1.05
Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology (1988) 1.02
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab (2000) 0.99
Different patterns of intestinal transit time and anorectal motility in painful and painless chronic constipation. Gut (1984) 0.98
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. J Neuroendocrinol (2008) 0.98
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion (1983) 0.98
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) (1999) 0.96
A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion (1984) 0.96
Detection of portal hypertension and esophageal varices by means of endoscopic ultrasonography. Scand J Gastroenterol Suppl (1986) 0.96
Action of secretin on pancreatic enzyme secretion in man. Studies on pure pancreatic juice. Gut (1984) 0.96
Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res (1999) 0.95
Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol (1999) 0.95
Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients. Ann Oncol (2002) 0.95
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study. Int J Obes Relat Metab Disord (2004) 0.94
Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord (1996) 0.94
The incidence of cough during treatment with angiotensin converting enzyme inhibitors. J Hypertens Suppl (1989) 0.94
Intraoperative ultrasonography in surgery for liver tumors. Surgery (1986) 0.93
Pancreolauryl test for pancreatic exocrine insufficiency. Am J Gastroenterol (1983) 0.93
Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation (1998) 0.93
Evidence-based medicine and ACE inhibition. J Cardiovasc Pharmacol (1998) 0.93
Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecol (2004) 0.92
The endocannabinoid system and energy metabolism. J Neuroendocrinol (2008) 0.92
Effects of cognitive-behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder. Int J Obes Relat Metab Disord (2002) 0.92
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study. Cancer Chemother Pharmacol (1988) 0.92
Ultrasonic endoscopy--the gastrointestinal wall. Scand J Gastroenterol Suppl (1984) 0.92
Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men. Int J Obes Relat Metab Disord (1997) 0.91
Increased intralymphocytic sodium content in essential hypertension: an index of impaired Na+ cellular metabolism. Clin Sci (Lond) (1981) 0.91
Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive diet. Nutr Metab Cardiovasc Dis (2008) 0.91
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab (2003) 0.90
An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetes. J Endocrinol Invest (2006) 0.90
The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.90
Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying. Dig Dis Sci (1986) 0.89
Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries. J Endocrinol Invest (1987) 0.89
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens (2004) 0.89
Ultrasonographic study of portal venous system in portal hypertension and after portosystemic shunt operations. Surgery (1984) 0.88
The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women. J Endocrinol Invest (1991) 0.88
Continuous care in the treatment of obesity: an observational multicentre study. J Intern Med (2005) 0.88
Assessment of nutritional status in Crohn's disease in remission or low activity. Hepatogastroenterology (1984) 0.87
The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf) (1993) 0.87
Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension. Hypertension (1983) 0.87
Psychiatric distress and health-related quality of life in obesity. Diabetes Nutr Metab (2003) 0.87
Effects of a low-salt diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in young subjects with borderline hypertension. Clin Sci (Lond) (1981) 0.87
Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent. J Neuroendocrinol (2010) 0.87
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer (1998) 0.87
Analysis with OKT monoclonal antibodies of T-lymphocyte subsets present in blood and liver of patients with chronic active hepatitis. Liver (1984) 0.86
ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int J Obes Relat Metab Disord (1999) 0.86
Tubercular involvement of the thyroid gland: a report of two cases. Horm Res (1999) 0.86
Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res (1993) 0.86
Health-related quality of life in obesity: the role of eating behaviour. Diabetes Nutr Metab (2000) 0.85
Anal manometry in constipated patients. Gastroenterology (1979) 0.85
How many sites of action for endocannabinoids to control energy metabolism? Int J Obes (Lond) (2006) 0.85
Captopril and hydrochlorothiazide: rationale for their combination. Br J Clin Pharmacol (1987) 0.85
Cardiovascular lesions in chronic pancreatitis: a prospective study. Dig Dis Sci (1982) 0.84
Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord (1994) 0.84
Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism (1994) 0.84